The Royal Marsden NHS Foundation Trust
ANMI PSMA kit VEAT notice
This is a contract result notice, not an open opportunity. Details from the official award data.
The procurement contact named on the official notice.
.The Royal Marsden Hospital requires purchase of ANMI PSMA Setrile 360 VIALS and ANMI Elution Tools Gen A to treat prostate cancer.
ANMI PSMA Setrile 360 Vials and ANMI Elution Tools Gen A is the only viable kit for imaging of prostate cancer, disease progression or staging of cancer in UK.
There is no licensed product in the UK at the moment, XIEL is the only official UK Distributor of the ANMI HBEDCC-11 PSMA Kit and follows the Regulated Import Pathway approved by the MHRA for this product.
What this notice demands of you
1 named, none in explicit obligation language. Each one is quoted from the notice.
There is no licensed product in the UK at the moment, XIEL is the only official UK Distributor of the ANMI HBEDCC-11 PSMA Kit and follows the Regulated Import Pathway approved by the MHRA for this product.
Matched against the notice text, so this is a floor — the tender pack will demand things the notice never mentions. “Says must” means the quoted sentence itself used obligation language; anything ambiguous is left as a mention.
Make the case to bid
Reveal who to approach at The Royal Marsden NHS Foundation Trust, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- ocds-h6vhtk-0337ca
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 012588-2022
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
The Royal Marsden NHS Foundation Trust’s tender network